Previous Article | Next Article 
Infection and Immunity, February 2001, p. 1175-1177, Vol. 69, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.1175-1177.2001
Macrophage-Derived Cell Lines Do Not Express Proinflammatory
Cytokines after Exposure to Bacillus anthracis Lethal
Toxin
James L.
Erwin,1,2
Luis M.
DaSilva,3
Sina
Bavari,3
Stephen F.
Little,4
Arthur M.
Friedlander,1 and
Tran C.
Chanh1,2,*
Headquarters,1
Division of Virology,2 Division
of Toxinology,3 and Division of
Bacteriology,4 United States Army Medical
Research Institute of Infectious Diseases, Fort Detrick, Frederick,
Maryland 21702-5011
Received 20 July 2000/Returned for modification 8 September
2000/Accepted 7 November 2000
 |
ABSTRACT |
We present evidence that Bacillus anthracis lethal
toxin (LT) suppresses rather than induces proinflammatory cytokine
production in macrophages. Suppression is observed with extremely low
levels of LT and involves inhibition of transcription of cytokine
messenger RNA. Thus, LT may contribute to anthrax pathogenesis by
suppressing the inflammatory response.
 |
TEXT |
Lethal toxin (LT), produced by
Bacillus anthracis, the etiologic agent for anthrax,
is composed of two subunits, protective antigen (PA) and lethal factor
(LF). PA is a pore-forming protein that mediates the entry of LF into
the cell (3, 4). LF is a metalloprotease that exhibits an
exclusive cytotoxicity for monocytes and macrophages. LF has been shown
to cleave short N-terminal fragments from mitogen or extracellular
signal-regulated kinase kinase 1 (MEK1) MEK2, and MEK3, the upstream
activators of extracellular signal-regulated kinase 1 (ERK1), ERK2, and
p38, respectively (1, 5, 7).
Effect of LT on macrophage cytokine expression.
The response
of LT-sensitive (RAW 264.7, J774A.1) and LT-resistant (IC-21)
murine macrophage cell lines to low levels of anthrax LT was
investigated. A saturating level of PA (0.1 µg/ml; S. F. Little, unpublished observations) and various concentrations of LF were added to the cultures (Table 1).
Each of the three cell lines expressed significant levels of tumor
necrosis factor alpha (TNF-
) and interleukin-1
(IL-1
) upon
exposure to lipopolysaccharide (LPS) (Eschericha coli
026:B6; Sigma-Aldrich, St. Louis, Mo.) (data not shown). Expression of
TNF-
was apparent within 30 min of exposure, well within the time
during which the cells were still viable upon exposure to a lytic
concentration of LT. Parallel cultures of macrophages were exposed to
LT for 6 h and assessed for viability [by a
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2-H-tetrazolium, bromide (MTT) reduction assay (Roche Molecular Biochemicals,
Indianapolis, Ind.)] or cytokine expression by a capture
enzyme-linked immunosorbent assay (ELISA) (BioSource
International, Camarillo, Calif, and R&D Systems, Minneapolis,
Minn.). None of the cell lines expressed either TNF-
or
IL-1
at any level of toxin administered to the cultures (Table 1).
Inhibition of cytokine expression.
Expression of TNF-
by
macrophages in response to LPS involves at least three MAP
kinase pathways (6). Thus, LPS-induced cytokine
expression was a logical choice for examining the effect of LT upon
ERK-dependent processes. Since the LF protease attacks the upstream
activators of ERK isoforms (MEKs), it seemed likely that LT would have
an inhibitory effect upon cytokine expression. Because some degree of
killing in J774A.1 cultures was observed with as little as
10
4 µg of LT/ml, but not with lesser concentrations
(Table 1 and data not shown), 10
6 µg of LT/ml was
used as a sublytic amount (Table 1) to determine if low concentrations
of toxin had any effect on cytokine expression by the cells.
Preincubating macrophages with LT progressively inhibited the ability
of the cells to express TNF-
upon subsequent exposure to LPS (Fig.
1). For J774A.1 cells, inhibition of
TNF-
was detectable within 1 h of exposure to LT, reaching
a maximum by 4 h after exposure. Inhibition of TNF-
in
RAW 264.7 cells became apparent by 4 h posttreatment and was
almost complete after overnight treatment. IC-21 cells displayed
pronounced inhibition of TNF-
within 1 h of LT treatment, and
in some experiments, coincubating the cells with LT and LPS was
sufficient to inhibit cytokine expression. The cultures were viable by
MTT assay (data not shown); thus, lack of response to LPS could not be
accounted for by cell death. No inhibition of TNF-
was detected with
0.01 pg of LT/ml, and higher levels of LT failed to accelerate the time
course of inhibition. Inhibition was specific to LT, as neither LF nor
PA added alone had any effects on TNF-
expression (data not shown).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Inhibition of LPS-induced TNF- expression. RAW 264.7 (open bars), J774A.1 (hatched bars), and IC-21 (cross-hatched
bars) macrophages were cultured with media alone, LPS alone, or LT
alone, were cocultured with LT and LPS, or were pretreated with LT (1 pg/ml) for 1, 4, or 16 h before LPS stimulation (10 ng/ml) for an
additional 6 h. TNF- expression was determined by cytokine
capture ELISA. Data are the means ± standard errors of the results of
two experiments with triplicate samples.
|
|
Anthrax LT and expression of cytokine RNAs.
Because ERK
pathways are involved in LPS-induced transcription of TNF-
mRNA
(2), it is reasonable to expect that LT might inhibit
LPS-induced transcription. Levels of RNA encoding IL-1
and TNF-
,
as well as IL-1
, IL-1 receptor antagonist (IL-1RA), and IL-6, were
examined in murine macrophage cell lines. The cell lines were cultured
overnight in the presence or absence of 10
6 µg of LF/ml
plus 0.1 µg of PA/ml. After incubation, LPS was added to the cells,
which were cultured for 30 min or 2, 4, or 24 h and lysed. A
control culture with no treatment and a culture that received only LT
were included in the experiments. RNAs were harvested and probed with
multi-probe templates (BD Pharmingen, San Diego, Calif.) that included
probes for TNF-
and IL-6 (Fig. 2A) or
IL-1
, IL-1
, and IL-1RA (Fig. 2B). Target RNA (2 µg) was reacted
with mouse cytokine primer sets mCK-3b and mCK-2b (2.9 × 105 cpm/µl) labeled with [33P]UTP,
after which free probe and single-stranded RNAs were digested with
RNases. The protected RNA was resolved on a 5%
polyacrylamide gel electrophoresis gel. The gel was then transferred
onto Whatman paper, dried, and exposed to an X-ray film (X-AR; Eastman
Kodak Co., Rochester, N.Y.). Culturing the cells with LT alone had no effect on expression of cytokine RNAs while LPS induced increases in
the levels of mRNA for TNF-
, IL-1
, IL-1
, IL-1RA, and IL-6. Preincubation with LT inhibited the observed LPS-induced increase in
the levels of these RNAs. Inhibition persisted over
the 24-h time course of the experiments. As is demonstrated in
Fig. 2B, IL-1
mRNA was induced by LPS in RAW 264.7 cells and
was completely inhibited by LT pretreatment. Similar results
were observed for J774A.1 and IC-21 macrophages; however, the level of
mRNA expression induced by LPS alone was not as high as it was for RAW
264.7 macrophages (data not shown).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of cytokine expression by RNase protection
assay. RNase protection assays were performed to measure RNA expression
for TNF- and IL-6 (A) or IL-1 , IL-1 , and IL-1RA (B). Lanes 1 to 5, cells cultured with medium for 16 h before addition of 10 ng
of LPS/ml; lanes 6 to 10, cells cultured with 1 pg of LT/ml for 16 h before addition of 10 ng of LPS/ml. Lanes 1 and 6, cells cultured
without LPS; lanes 2 and 7, cells cultured with LPS for 30 min; lanes 3 and 8, cells cultured with LPS for 2 h; lanes 4 and 9, cells
cultured with LPS for 4 h; lanes 5 and 10, cells cultured with LPS
for 24 h.
|
|
In summary, we have shown that LT does not induce proinflammatory
cytokine expression. Moreover, LPS-induced cytokine expression is
inhibited by LT. Our findings suggest that LT may act to impair host
response in reducing the inflammatory response and thus enhance bacterial virulence.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: U.S. Army
Medical Research Institute of Infectious Diseases, 1425 Porter St.,
Fort Detrick, Frederick, MD 21702-5011. Phone: (301) 619-4795. Fax: (301) 619-4268. E-mail:
Tran.Chanh{at}DET.AMEDD.army.mil.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Duesbery, N. S.,
C. P. Webb,
S. H. Leppla,
V. M. Gordon,
K. R. Klimpel,
T. D. Copeland,
N. G. Ahn,
M. K. Oskarsson,
K. Fukasawa,
K. D. Paull, and G. F. Vande Woude.
1998.
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science
280:734-737[Abstract/Free Full Text].
|
| 2.
|
English, J.,
G. Pearson,
J. Wilsbacher,
J. Swantek,
M. Karandikar,
S. Xu, and M. H. Cobb.
1999.
New insights into the control of MAP kinase pathways.
Exp. Cell Res.
253:255-270[CrossRef][Medline].
|
| 3.
|
Friedlander, A. M.
1986.
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
J. Biol. Chem.
261:7123-7126[Abstract/Free Full Text].
|
| 4.
|
Klimpel, K. R.,
S. S. Molloy,
G. Thomas, and S. H. Leppla.
1992.
Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.
Proc. Natl. Acad. Sci. USA
89:10277-10281[Abstract/Free Full Text].
|
| 5.
|
Pellizzari, R.,
C. Guidi-Rontani,
G. Vitale,
M. Mock, and C. Montecucco.
1999.
Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFN gamma-induced release of NO and TNFalpha.
FEBS Lett.
462:199-204[CrossRef][Medline].
|
| 6.
|
Swantek, J. L.,
M. H. Cobb, and T. D. Geppert.
1997.
Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF- ) translation: glucocorticoids inhibit TNF- translation by blocking JNK/SAPK.
Mol. Cell. Biol.
17:6274-6282[Abstract].
|
| 7.
|
Vitale, G.,
R. Pellizzari,
C. Recchi,
G. Napolitani,
M. Mock, and C. Montecucco.
1998.
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Biochem. Biophys. Res. Commun.
248:706-711[CrossRef][Medline].
|
Infection and Immunity, February 2001, p. 1175-1177, Vol. 69, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.1175-1177.2001
This article has been cited by other articles:
-
Cleret, A., Quesnel-Hellmann, A., Vallon-Eberhard, A., Verrier, B., Jung, S., Vidal, D., Mathieu, J., Tournier, J.-N.
(2007). Lung Dendritic Cells Rapidly Mediate Anthrax Spore Entry through the Pulmonary Route. J. Immunol.
178: 7994-8001
[Abstract]
[Full Text]
-
Drysdale, M., Olson, G., Koehler, T. M., Lipscomb, M. F., Lyons, C. R.
(2007). Murine Innate Immune Response to Virulent Toxigenic and Nontoxigenic Bacillus anthracis Strains. Infect. Immun.
75: 1757-1764
[Abstract]
[Full Text]
-
Sherer, K., Li, Y., Cui, X., Eichacker, P. Q.
(2007). Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy. Am. J. Respir. Crit. Care Med.
175: 211-221
[Abstract]
[Full Text]
-
Ribot, W. J., Panchal, R. G., Brittingham, K. C., Ruthel, G., Kenny, T. A., Lane, D., Curry, B., Hoover, T. A., Friedlander, A. M., Bavari, S.
(2006). Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival. Infect. Immun.
74: 5029-5034
[Abstract]
[Full Text]
-
Crawford, M. A., Aylott, C. V., Bourdeau, R. W., Bokoch, G. M.
(2006). Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity.. J. Immunol.
176: 7557-7565
[Abstract]
[Full Text]
-
McConnell, M. J., Hanna, P. C., Imperiale, M. J.
(2006). Cytokine Response and Survival of Mice Immunized with an Adenovirus Expressing Bacillus anthracis Protective Antigen Domain 4. Infect. Immun.
74: 1009-1015
[Abstract]
[Full Text]
-
Rainey, G. J. A., Wigelsworth, D. J., Ryan, P. L., Scobie, H. M., Collier, R. J., Young, J. A. T.
(2005). Receptor-specific requirements for anthrax toxin delivery into cells. Proc. Natl. Acad. Sci. USA
102: 13278-13283
[Abstract]
[Full Text]
-
Tournier, J.-N., Quesnel-Hellmann, A., Mathieu, J., Montecucco, C., Tang, W.-J., Mock, M., Vidal, D. R., Goossens, P. L.
(2005). Anthrax Edema Toxin Cooperates with Lethal Toxin to Impair Cytokine Secretion during Infection of Dendritic Cells. J. Immunol.
174: 4934-4941
[Abstract]
[Full Text]
-
Fang, H., Cordoba-Rodriguez, R., Lankford, C. S. R., Frucht, D. M.
(2005). Anthrax Lethal Toxin Blocks MAPK Kinase-Dependent IL-2 Production in CD4+ T Cells. J. Immunol.
174: 4966-4971
[Abstract]
[Full Text]
-
Panchal, R. G., Halverson, K. M., Ribot, W., Lane, D., Kenny, T., Abshire, T. G., Ezzell, J. W., Hoover, T. A., Powell, B., Little, S., Kasianowicz, J. J., Bavari, S.
(2005). Purified Bacillus anthracis Lethal Toxin Complex Formed in Vitro and during Infection Exhibits Functional and Biological Activity. J. Biol. Chem.
280: 10834-10839
[Abstract]
[Full Text]
-
Comer, J. E., Galindo, C. L., Chopra, A. K., Peterson, J. W.
(2005). GeneChip Analyses of Global Transcriptional Responses of Murine Macrophages to the Lethal Toxin of Bacillus anthracis. Infect. Immun.
73: 1879-1885
[Abstract]
[Full Text]
-
Bergman, N. H., Passalacqua, K. D., Gaspard, R., Shetron-Rama, L. M., Quackenbush, J., Hanna, P. C.
(2005). Murine Macrophage Transcriptional Responses to Bacillus anthracis Infection and Intoxication. Infect. Immun.
73: 1069-1080
[Abstract]
[Full Text]
-
Park, J. M., Ng, V. H., Maeda, S., Rest, R. F., Karin, M.
(2004). Anthrolysin O and Other Gram-positive Cytolysins Are Toll-like Receptor 4 Agonists. JEM
200: 1647-1655
[Abstract]
[Full Text]
-
Pickering, A. K., Osorio, M., Lee, G. M., Grippe, V. K., Bray, M., Merkel, T. J.
(2004). Cytokine Response to Infection with Bacillus anthracis Spores. Infect. Immun.
72: 6382-6389
[Abstract]
[Full Text]
-
Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G.
(2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev.
68: 373-402
[Abstract]
[Full Text]
-
Gimenez, A. P., Wu, Y.-Z., Paya, M., Delclaux, C., Touqui, L., Goossens, P. L.
(2004). High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin. J. Immunol.
173: 521-530
[Abstract]
[Full Text]
-
Cordoba-Rodriguez, R., Fang, H., Lankford, C. S. R., Frucht, D. M.
(2004). Anthrax Lethal Toxin Rapidly Activates Caspase-1/ICE and Induces Extracellular Release of Interleukin (IL)-1{beta} and IL-18. J. Biol. Chem.
279: 20563-20566
[Abstract]
[Full Text]
-
Pickering, A. K., Merkel, T. J.
(2004). Macrophages Release Tumor Necrosis Factor Alpha and Interleukin-12 in Response to Intracellular Bacillus anthracis Spores. Infect. Immun.
72: 3069-3072
[Abstract]
[Full Text]
-
Cui, X., Moayeri, M., Li, Y., Li, X., Haley, M., Fitz, Y., Correa-Araujo, R., Banks, S. M., Leppla, S. H., Eichacker, P. Q.
(2004). Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.
286: R699-R709
[Abstract]
[Full Text]
-
Gold, J. A., Hoshino, Y., Hoshino, S., Jones, M. B., Nolan, A., Weiden, M. D.
(2004). Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracis. Infect. Immun.
72: 1291-1297
[Abstract]
[Full Text]
-
Kirby, J. E.
(2004). Anthrax Lethal Toxin Induces Human Endothelial Cell Apoptosis. Infect. Immun.
72: 430-439
[Abstract]
[Full Text]
-
Webster, J. I., Tonelli, L. H., Moayeri, M., Simons, S. S. Jr., Leppla, S. H., Sternberg, E. M.
(2003). Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc. Natl. Acad. Sci. USA
100: 5706-5711
[Abstract]
[Full Text]
-
Kim, S. O., Jing, Q., Hoebe, K., Beutler, B., Duesbery, N. S., Han, J.
(2003). Sensitizing Anthrax Lethal Toxin-resistant Macrophages to Lethal Toxin-induced Killing by Tumor Necrosis Factor-alpha. J. Biol. Chem.
278: 7413-7421
[Abstract]
[Full Text]